Glenmede Trust’s Braskem BAK Stock Holding History

Glenmede Trust’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-315	Closed	-$2K	–	1299
2020 Q3	$2K	Sell	315 -186	-37%	-$1.6K	﹤0.01%	2240
2020 Q2	$4K	Sell	501 -256	-34%	-$2.2K	﹤0.01%	2109
2020 Q1	$11K	Hold	757	–	–	﹤0.01%	2378
2019 Q4	$11K	Hold	757	–	–	﹤0.01%	2378
2019 Q3	$11	Hold	757	–	–	﹤0.01%	2304
2019 Q2	$13	Hold	757	–	–	﹤0.01%	2253
2019 Q1	$19	Sell	757 -53	-7%	-$1.47K	﹤0.01%	2083
2018 Q4	$19	Buy	+810	New	+$22K	﹤0.01%	2007
2018 Q3	–	Sell	-733	Closed	-$19K	–	1467
2018 Q2	$19K	Buy	733 +40	+6%	+$1.03K	﹤0.01%	1729
2018 Q1	$18K	Hold	693	–	–	﹤0.01%	1994
2017 Q4	$18K	Sell	693 -21	-3%	-$600	﹤0.01%	1994
2017 Q3	$18K	Buy	714 +87	+14%	+$2.14K	﹤0.01%	2001
2017 Q2	$12K	Hold	627	–	–	﹤0.01%	2061
2017 Q1	$12K	Hold	627	–	–	﹤0.01%	2061
2016 Q4	$12K	Hold	627	–	–	﹤0.01%	2054
2016 Q3	$9K	Hold	627	–	–	﹤0.01%	2156
2016 Q2	$7K	Hold	627	–	–	﹤0.01%	2169
2016 Q1	$7K	Hold	627	–	–	﹤0.01%	2125
2015 Q4	$8K	Hold	627	–	–	﹤0.01%	2128
2015 Q3	$5K	Buy	627 +396	+171%	+$3.06K	﹤0.01%	2294
2015 Q2	$1K	Buy	+231	New	+$1.97K	﹤0.01%	2525

Other funds holding BAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Glenmede Trust's BAK Position: Q4 2020 in Review

Glenmede Trust sold out of Braskem (BAK) in Q4 2020, closing a stake of 315 shares — an estimated $2K sold.

Glenmede Trust first reported a position in BAK in Q2 2015 and held it in 21 quarters. The position peaked at $19K in Q2 2018. 34 funds tracked by Wall St. Rank hold BAK as of Q4 2020.

Glenmede Trust reported no remaining Braskem position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 315 Braskem shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Braskem in Q2 2015 and held it in 21 quarters.
Glenmede Trust's Braskem position peaked at $19K in Q2 2018.
34 funds tracked by Wall St. Rank held Braskem as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.